| ID | Name | CAS | Properties |
logPoct/wat |
| 124-510-7 |
5-Cholesten-3-«beta»,7-«alpha»,12-«alpha»,24,25-pentol, TMS, # 1
|
|
2 | 12.712 |
| 124-535-0 |
Pyrimidine, 6-oxo-5-acetyl-4-hydroxy-1,6-dihydro-
|
98792-81-5 |
2 | -0.804 |
| 124-546-8 |
Fluoxymesterone M (Androst-4-en-9A-fluoro-17A-methyl-3A,6B,11B,17B-tetrol), TMS
|
|
2 | 9.532 |
| 124-548-6 |
Gentisic acid, O,O'-bis(tert-butyldimethylsilyl)-, tert-butyldimethylsilyl ester
|
|
2 | 8.617 |
| 124-592-7 |
Glycine, N-(2-methyl-1-oxopropyl)-N-(trimethylsilyl)-, trimethylsilyl ester
|
55530-55-7 |
2 | 2.684 |
| 124-632-2 |
1-(4-Trimethylsilyloxycarbonylphenyl)-2-(pyrrolidin-1-yl)-butan-1-one
|
|
2 | 3.735 |
| 124-633-1 |
Benzoic acid, 4-(1-trimethylsilyloxy)-2-(pyrrolidin-1-yl)butyl-, trimethylsilyl ester
|
|
2 | 5.445 |
| 124-635-9 |
Pyrrolidin-2-one, 1-[1-(4-trimethylsilyloxycarbonylphenyl)butan-1-ol-2-yl]-, trimethylsilyl ether
|
|
2 | 4.972 |
| 124-636-8 |
Pyrrolidin-2-one, 1-[1-(4-trimethylsilyloxycarbonylphenyl)butan-1-one-2-yl]-
|
|
2 | 3.262 |
| 124-693-5 |
5-(Dichloromethyl)dimethylsilyloxy-2,6-dimethylnon-1-en-3-yne
|
|
2 | 4.935 |
| 124-721-3 |
2,8,9-Trioxa-5-aza-1-silabicyclo[3.3.3]undecane, 3,7-dimethyl-1-phenyl-
|
2097-20-3 |
2 | 0.989 |
| 124-724-0 |
3-Ethoxy-3-hydroxyacrylic acid, tert-butyldimethylsilyl ether, tert-butyldimethylsilyl ester
|
|
2 | 5.435 |
| 124-726-8 |
Prosta-8(12),13-dien-1-oic acid, 9-(ethoxyimino)-15-[(trimethylsilyl)oxy]-, trimethylsilyl ester, (13E,15S)-
|
56009-45-1 |
2 | 8.545 |
| 124-792-5 |
3«alpha»,6«alpha»,7«alpha»,12«alpha»-tetrahydroxy-5«beta»-C27-bile acid, methyl ester, TMS
|
|
2 | 10.971 |
| 124-794-3 |
3-oxy-7«alpha»,12«alpha»-dihydroxy-5«beta»-cholestanoate, methyl ester-trimethylsilyl ether
|
|
2 | 10.266 |
| 125-059-8 |
Butanoic acid, 2-[(tert-butyldimethylsilyl)oxy]-3-methyl-, tert-butyldimethylsilyl ester
|
|
2 | 5.581 |
| 125-141-6 |
Nigerotriose: aD-Glcp(1->3)-aDGlcp(1->3)-DGlc, oxime-TMS, isomer # 2
|
|
2 | 14.359 |
| 125-252-3 |
Pregn-4-en-17-ol, 3,20-bis[(trimethylsilyl)oxy]-, (3.beta.,20S)-
|
|
2 | 7.140 |
| 17-037-2 |
2,4,6,8,10-Pentaethyl-2,4,6,8,10-pentamethylcyclopentasiloxane
|
|
1 | 5.542 |
| 26-388-3 |
L-Leucine, N-(tert-butyldimethylsilyl)-N-methyl-, tert-butyldimethylsilyl ester
|
|
1 | 5.886 |
| 30-173-6 |
Ascorbic acid, 2,3,5,6-tetrakis-O-(tert-butyldimethylsilyl)-
|
|
1 | 9.579 |
| 35-212-7 |
Cyclobutanone, 3,3'-(dimethylsilyldioxy) bis-2,2,4,4-tetramethyl
|
|
1 | 3.729 |
| 50-602-7 |
3,11,17-tris[(Trimethylsilyl)oxy]androst-5-ene, (3«beta»,11«beta»,17«beta»)-
|
33287-29-5 |
1 | 8.219 |
| 55-461-9 |
1-Cyclopentadienyl-3-chloro-1,1,3,3-tetramethyl disiloxane
|
|
1 | 3.574 |
| 55-679-8 |
2,3-Dihydro-2-phenyl-1h-1,3,2-benzodiazaborole
|
2479-64-3 |
1 | 1.919 |
| 59-956-6 |
[1,2,5]Selenadiazolo[3,4-d]pyrimidin-7(6h)-one
|
7698-94-4 |
1 | -1.712 |
| 63-495-3 |
1,1,2,2-Tetramethyl-3,3,4,4-tetra(n-butyl)cyclotetrasilane
|
|
1 | 7.828 |
| 64-261-1 |
2,2'-((1,8-Dihydroxy-3,6-disulfo-2,7-naphthylene)bis(azo)), dibenzene arsonic acid
|
1668-00-4 |
1 | 0.697 |
| 66-053-0 |
L-Proline, 4-[(tert-butyldimethylsilyl)oxy]-1-(tert-butyldimethylsilyl)-, tert-butyldimethylsilyl ester
|
|
1 | 7.005 |
| 66-642-6 |
D-Glucopyranose, 4-O-[2,3,4,6-tetrakis-O-(trimethylsilyl)-«beta»-D-galactopyranosyl]-1,2,3,6-tetrakis-O-(trimethylsilyl)-
|
55529-68-5 |
1 | 9.476 |
| 67-044-9 |
Inositol, 1,2,3,4,5,6-hexakis-O-(trimethylsilyl)-, allo-
|
29267-02-5 |
1 | 7.321 |
| 67-409-4 |
15-Hydroxy-7-oxodehydroabietic acid, trimethylsilyl ester, 15-trimethylsilyl ether
|
|
1 | 6.802 |
| 69-747-7 |
17-Methyl-3,17-bis[(trimethylsilyl)oxy]androstane, (3«beta»,5«alpha»,17«beta»)-
|
39780-71-7 |
1 | 7.859 |
| 70-115-6 |
(R)-3-Hydroxybutyric acid, tert-butyldimethylsilyl ether, tert-butyldimethylsilyl ester
|
|
1 | 5.335 |
| 70-328-0 |
5«beta»-Pregnan-3«alpha»,17«alpha»,20«alpha»-triol, 3,20-bis(trimethylsilyl) ether
|
|
1 | 7.220 |
| 72-804-9 |
Bis-(3-[2-(3-methylpyrazoxy)]-2,2,4,4--tetramethyl-1-cyclobutoxy) dimethylsilane
|
|
1 | 5.683 |
| 77-207-7 |
1,3,5,7,9,11,13,15-Octabutylpentacyclo[13.1.1.13,5.17,9.111,13]octasiloxane
|
|
1 | 10.166 |
| 77-235-6 |
2,4,6,8-Tetraethyl-2,4,6,8-tetraphenylcyclotetrasiloxane
|
|
1 | 5.544 |
| 77-531-7 |
2,4,6,8-Tetrabutyl-2,4,6,8-tetramethyl-1,3,5,7,2,4,6,8-tetraoxatetrasilocane
|
|
1 | 7.555 |
| 78-682-9 |
9,9,10,10-TETRACHLORO-9,10-DISILA-9,10-DIHYDROANTHRACENE
|
|
1 | 2.068 |
| 85-413-9 |
2,4,6,8-Tetraethyl-2,4,6,8-tetramethylcyclotetrasiloxane
|
7623-01-0 |
1 | 4.434 |
| 87-289-6 |
1,1,3,3-Tetramethyl-2,2,4,4-tetra(n-butyl)cyclotetrasilane
|
|
1 | 7.828 |
| 87-859-3 |
2-Methoxy-3,16,17-tris[(trimethylsilyl)oxy]estra-1,3,5(10)-triene, (16«alpha»,17«beta»)-
|
51497-48-4 |
1 | 7.815 |
| 95-603-7 |
2,4,6-Triethyl-2,4,6-triphenyl-1,3,5,2,4,6-trioxatrisilinane
|
|
1 | 4.158 |
| 96-638-8 |
1,2,5-Selenadiazole-3-carboxamide, 4-amino-n-methyl-
|
7698-91-1 |
1 | -0.950 |
| 97-439-8 |
3,3'-(Dimethylsilyldioxy)bis-2,2,4,4-tetramethyl cyclobutanol
|
116434-98-1 |
1 | 3.312 |
| 115-454-0 |
D,L-Alanine, N-(tert-butyldimethylsilyl)-N-methyl-, tert-butyldimethylsilyl ester
|
|
1 | 4.860 |
| 115-617-9 |
Methyl 5-.beta.-cholan-3,7,12-trione-24-oate, oxime, TMS # 2
|
|
1 | 9.077 |
| 116-539-5 |
3.alpha.,15.alpha.-dihydroxy-5.beta.-androstan-17-one, MO-TMS
|
|
1 | 8.287 |
| 116-661-9 |
3,4-Dihydroxy-dl-phenylalanine, N,O,O'-tris(trimethylsilyl)-, trimethylsilyl ester
|
|
1 | 5.828 |
| 118-463-7 |
L-Proline, 1-(trimethylsilyl)-4-[(trimethylsilyl)oxy]-, trimethylsilyl ester, trans-
|
55429-66-8 |
1 | 3.494 |
| 118-703-0 |
2-Propenoic acid, 3-[3,5-dimethoxy-4-[(trimethylsilyl)oxy]phenyl]-, trimethylsilyl ester, (E)-
|
67460-48-4 |
1 | 4.309 |
| 119-908-2 |
5-Pregnene-3.beta.,16.alpha.,20.alpha.,21-tetrol, EO-TMS
|
|
1 | 9.687 |
| 120-903-5 |
Methyl 5-.beta.-cholan-3,7-dione-24-oate, oxime, TMS # 1
|
|
1 | 8.259 |
| 121-093-4 |
5.beta.-Pregnane-20-one-3.alpha.,21-diol, EO-TMS, # 2
|
|
1 | 7.719 |
| 122-215-7 |
Methyl 5-.beta.-cholan-3,7,12-trione-24-oate, oxime, TMS # 1
|
|
1 | 9.077 |
| 122-497-5 |
Propanoic acid, 2-[(tert-butyldimethylsilyl)amino]-2-methyl-, tert-butyldimethylsilyl ester
|
|
1 | 4.908 |
| 123-599-1 |
11.alpha.,15.alpha.-dihydroxy-9-ketoprost-13-enoic acid, MO-TMS # 2
|
|
1 | 9.310 |
| 124-023-8 |
4-Cholesten-7-.alpha.,12-.alpha.-diol-3-one, TMS
|
|
1 | 9.257 |
|
« Previous Results
|